Axikin Pharmaceuticals Receives $6,000,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
    Axikin Pharmaceuticals
  • Mailing Address
    10835 Road To The Cure San Diego, CA 92121 USA
  • Company Description
    The Axikin discovery biology and portfolio of small molecules focuses on novel GPCR and kinase targets central to the inflammatory process, the antagonism of which is predicted to ameliorate allergic respiratory disorders such as rhinitis and asthma, in addition to significantly impacting the inflammation observed in COPD.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    This filing includes amounts receivable by the Company upon the exercise of Warrants to purchase shares of the Company’s Common Stock, assuming no cashless exercise. Such Warrants have not yet been issued. Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy